ArticleCirculation reports2021

Effect of the Sodium-Glucose Cotransporter 2 Inhibitor Canagliflozin for Heart Failure With Preserved Ejection Fraction in Patients With Type 2 Diabetes.

Tomoya Ueda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.